Smith & Nephew plc SNN

NYS: SNN | ISIN: US83175M2052   31/03/2023
27,91 USD (+1,94%)
(+1,94%)   31/03/2023
Grafiek Smith & Nephew plc Grafiek Smith & Nephew plc
woensdag 17 mei 2023
Uitbetaling dividend: 0,46 USD per aandeel. Ex-dividend op 30/03/2023.

Smith & Nephew plc in het nieuws

23 maart 2023 · New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques · Persbericht

8 maart 2023 · Smith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual Meeting · Persbericht

7 maart 2023 · Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting · Persbericht

7 maart 2023 · Smith+Nephew Sports Medicine advances procedural innovation by launching the QUADTRAC™ Quadriceps Tendon Harvest Guide System and expanded family of ULTRABUTTON™ Adjustable Fixation Devices for ACL reconstruction · Persbericht

6 maart 2023 · Smith+Nephew's VISIONAIRE™ Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation · Persbericht

30 januari 2023 · Smith+Nephew receives Innovative Technology designation from Vizient for LEAF™ Patient Monitoring System · Persbericht

1 november 2022 · Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution · Persbericht

26 september 2022 · Smith+Nephew first to market with revision knee indication on robotics platform · Persbericht

21 september 2022 · Smith+Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies · Persbericht

14 september 2022 · New randomized controlled trial shows that addition of Smith+Nephew's REGENETEN™ Bioinductive Implant delivers 86% reduction in rotator cuff re-tear rates at 12 months · Persbericht

336x280

Profiel Smith & Nephew plc

Gezondheidstechnologie
Medische Specialiteiten
Productie
Productie van chirurgische apparatuur

CEO: Roland Diggelmann

Werknemers: 18.581

Aandelen Smith & Nephew plc

Beurswaarde: 11,96 miljard USD

Effecten: 436,68 miljoen

Winst per aandeel (12 maand):  PLUS

Koers-winstverhouding:  PLUS

Beta: 0,76

Mijn selecties